{
    "title": "108_hr4903",
    "content": "The Medicare Advantage and Prescription Drug Accountability Act of 2004 requires reasonable return of benefits, financial transparency, beneficiary sign-off, annual accountability reports, auditing of actuarial equivalency, and a report comparing costs and benefits under different Medicare plans. The Medicare Advantage Plans must negotiate for minimum loss and maximum administrative cost ratios to ensure that benefits are in line with revenues collected under the contract. The Medicare Advantage Plans must negotiate for minimum loss and maximum administrative cost ratios to ensure benefits align with revenues collected under the contract. The Secretary will establish ratios based on private health insurance plans, Medicare parts A and B, and health benefits plans under the Federal Employees Health Benefits Program. Additionally, there will be an audit of administrative costs and compliance with the Federal Acquisition Regulation. The amendments to section 1395w-27(d)(2)(B) involve changes related to compliance with administrative cost requirements under the Federal Acquisition Regulation for prescription drug plans under Medicare Part D. These amendments will apply to contracts starting after the enactment of the Act. SEC. 3. FINANCIAL TRANSPARENCY. Medicare Advantage Plans must provide annual financial transparency information to the Secretary, including compliance with requirements and a breakdown of administrative costs, profits, and investment income. Medicare Advantage Plans are required to provide financial transparency information to the Secretary, including details on compliance, administrative costs, profits, and investment income. Amendments to the Social Security Act now include periodic auditing for prescription drug plans under MA plans. These changes apply to reporting information for contract years. The amendments made by section 2 apply to reporting information for contract years. SEC. 4. BENEFICIARY SIGN-OFF. Medicare Advantage Plans require beneficiary sign-off in the election process, acknowledging potential changes in premiums, cost-sharing, benefits, possible loss of provider coverage, and plan termination. The amendment allows for termination of the plan at the beginning of any period and variations in premiums and benefits based on location. It applies to prescription drug plans under part D of Medicare, with an effective date determined by the Secretary of Health and Human Services. SEC. 5. ANNUAL ACCOUNTABILITY REPORTS. Amends Section 1856 of the Social Security Act to establish standards and require an annual accountability report for Medicare Advantage plans. The Secretary is required to compile and transmit an annual Medicare Advantage accountability report to Congress, starting from 2004. The report will include an analysis of cost-sharing and premiums variation among MA plans, a comparison of payments to MA plans with fee-for-service programs, and recommendations for legislative changes. The Secretary is mandated to compile an annual Medicare Advantage accountability report to Congress, starting from 2004. The report will analyze cost-sharing and premiums variation among MA plans, compare payments to MA plans with fee-for-service programs, and provide recommendations for legislative changes. Additionally, there will be a Prescription Drug Accountability Report with an Annual Accountability Report subsection added. The Secretary is required to compile an annual prescription drug accountability report for Congress starting in 2006. The report will include information on prescription drug plans similar to that provided for MA plans. SEC. 6. AUDITING OF ACTUARIAL EQUIVALENCY. The text chunk discusses the periodic audits of actuarial equivalency determinations for Medicare Advantage Plans and Prescription Drug Plans under the Social Security Act. The Inspector General of the Department of Health and Human Services will audit determinations made by the Secretary to ensure only plans with actuarially equivalent benefits are approved. The new paragraph requires periodic auditing of actuarial equivalency determinations for prescription drug plans, following the same provisions as for Medicare Advantage plans under the Social Security Act. The Secretary of Health and Human Services must provide a report to Congress comparing costs and benefits of Medicare Advantage plans, Medicare supplemental policies, and fee-for-service Medicare within a year of this Act."
}